medicines

This report by OCU and Salud por Derecho para No es Sano analyzes the situation and the impact of shortages in Spain and Europe. In Spain alone, supply problems have doubled from 2015 to 2019, especially affecting drugs for cardiovascular diseases, infections and cancers. The study denounces the opacity around the true causes of the shortages which, in many cases, are due to commercial strategies of the pharmaceutical industry to put pressure on governments when setting prices or to favor the entry into the market of more profitable drugs.

27/10/2020
27/10/2020

Shortages and shortages of medicines

This report by OCU and Salud por Derecho para No es Sano analyzes the situation and the impact of shortages in Spain and Europe. In Spain alone, supply problems have doubled from […]
Do you like it?
Seguir leyendo
10/06/2020
10/06/2020

Proposals to ensure access to vaccines, medicines and medical supplies

At the beginning of the COVID-19 pandemic, the It’s Not Healthy campaign sent this document to the Government and political parties with a package of proposals on pharmaceutical policy that entails a […]
Do you like it?
Seguir leyendo
10/05/2018
10/05/2018

Cancer drugs: high prices and inequality

The report prepared by No es Sano confirms that cancer treatments are one of the groups of drugs with the highest prices and that generate the most income for the pharmaceutical industry. […]
Do you like it?
Seguir leyendo